Authors
Latest:
Central RBM Supports Reduced Cost, Higher Data QualityImplementing centralized risk-based monitoring can help meet strict GCP requirements for study conduct, oversight, and recording.
Latest:
What the Future of Study Review Processes Should Look LikeInsights from Bayer’s study review process showcases importance of incorporating feedback from a wider audience of stakeholders.
Latest:
Four-Steps to Accelerate Study Start-up CyclesIdentifying KPIs, benchmarks, key data points, and an actionable plan are all keys to accelerating study start-up cycles.
Latest:
How Today’s Digitally Driven Research Could Drive CAR T-cell Therapy Protocols of the FutureNew protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.
Latest:
What Patients Expect from Clinical Trials in the COVID-19 EraKey takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.
Latest:
Targeting Patient PopulationKeys to ensuring your clinical trials better reflect your target population.
Latest:
At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ DeviceLaboratory services organization focuses on easing patient and site burden with improved collection device.
Latest:
How to Address—and Overcome—Operational Challenges in Master Protocol StudiesTrials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
Latest:
Evaluation of Different NLP Models for Parsing and Extraction of Clinical Data from Scientific ArticlesNatural language processing models are able to automate the extraction of pertinent information from a vast array of scientific literature.
Latest:
The Impact of Automated Safety Document Distribution on Pharmacovigilance and Patient SafetyAutomating process can reduce time and resources lost from using manual steps and allows stakeholders to maintain compliance.
Latest:
Emerging Practices Employing CDISC Standards in Clinical TrialsNow that the industry has gotten some experience with CDISC standards, teams are aiming to get more from their standardization efforts.
Latest:
At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ DeviceLaboratory services organization focuses on easing patient and site burden with improved collection device.
Latest:
Unknowns That Can Make or Break a Non-Opioid Analgesic Clinical TrialNew and renewed approaches to improve chances of success in developing non-addictive drugs for chronic pain.
Latest:
A Primer on Clinical Trial Virtual Waiting RoomsExploring their unique opportunity in increasing study enrollment levels.
Latest:
Establishing Metrics and Standardization for Non-CRF Data in EDCWhile Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.
Latest:
From Words to Action: Advancing Efforts to Reduce the Racial Gap in Clinical ResearchDespite repeated calls from the FDA, patient advocates, and scholars for the need to address demographic disparities in clinical research, White participants still remain overrepresented while racial minority participants remain underrepresented in clinical trials.
Latest:
Introducing PALADINFirst-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
Latest:
Future of Clinical Trial Documentation Management: eTMF Integrated with BlockchaineTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
Latest:
ePROs in Oncology: Breaking Through Barriers for Better Drug Development and Higher Quality CareIndustry now leveraging reporting system to empower patients and improve research.
Latest:
Understanding the Complexities of Diversifying Clinical TrialsTufts Center for the Study of Drug Development and Biogen recently conducted a study to inform growing interest in improving diversity of clinical trial participation. The results of this research provide insights into increasing the community of minority investigators and study staff and presenting greater access to clinical trials among minority study volunteers.
